These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31375337)
21. [Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis]. Yuan BJ; Liu ZZ; Ding XR; Zou JM Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):96-8. PubMed ID: 16600114 [TBL] [Abstract][Full Text] [Related]
22. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734 [TBL] [Abstract][Full Text] [Related]
23. [Viruses, bacteria, drugs, allergies. What is behind exanthemas?]. Schulz H MMW Fortschr Med; 2001 Apr; 143(17):35-7. PubMed ID: 11490503 [No Abstract] [Full Text] [Related]
24. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS). Miyagawa F; Asada H Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052 [TBL] [Abstract][Full Text] [Related]
25. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia. Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676 [TBL] [Abstract][Full Text] [Related]
26. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. Shearer WT; Easley KA; Goldfarb J; Rosenblatt HM; Jenson HB; Kovacs A; McIntosh K J Allergy Clin Immunol; 2000 Sep; 106(3):559-66. PubMed ID: 10984378 [TBL] [Abstract][Full Text] [Related]
27. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366 [TBL] [Abstract][Full Text] [Related]
28. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
29. Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions. Ushigome Y; Mizukawa Y; Kimishima M; Yamazaki Y; Takahashi R; Kano Y; Shiohara T Clin Exp Allergy; 2018 Nov; 48(11):1453-1463. PubMed ID: 30112775 [TBL] [Abstract][Full Text] [Related]
30. Elevated serum soluble Fas ligand is a promising marker of testicular toxicity induced by epirubicin in rats. Geng J; Fan J; Jiang HW; Fang ZJ; Wang X; Sun JL; Ding Q; Chen G Toxicol Lett; 2009 Apr; 186(2):96-103. PubMed ID: 19429229 [TBL] [Abstract][Full Text] [Related]
31. Correlation of loss of CD4 T cells with plasma levels of both soluble form Fas (CD95) Fas ligand (FasL) in HIV-infected infants. Hosaka N; Oyaizu N; Than S; Pahwa S Clin Immunol; 2000 Apr; 95(1 Pt 1):20-5. PubMed ID: 10794428 [TBL] [Abstract][Full Text] [Related]
32. Pleural effusion and serum soluble fas-ligand levels are elevated in different clinical conditions. Wang PS; Chen YM; Hsieh YL; Yu CF; Tsai CM; Perng RP Lung; 2002; 180(1):25-32. PubMed ID: 12105754 [TBL] [Abstract][Full Text] [Related]
33. Skin-Homing IL-13-Producing T Cells Expand in the Circulation of Patients with Drug Rash with Eosinophilia and Systemic Symptoms. Teraki Y; Fukuda T Dermatology; 2017; 233(2-3):242-249. PubMed ID: 28601883 [TBL] [Abstract][Full Text] [Related]
34. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988 [TBL] [Abstract][Full Text] [Related]
35. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction. Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243 [TBL] [Abstract][Full Text] [Related]
36. Cord blood soluble Fas ligand and pediatric atopic dermatitis. Su KW; Chen PC; Wang IJ Allergy Asthma Proc; 2011; 32(5):366-71. PubMed ID: 22195689 [TBL] [Abstract][Full Text] [Related]
38. Soluble Fas ligand-susceptible "memory" cells in mice but not in human: potential role of soluble Fas ligand in deletion of auto-reactive cells. Kim S; Ki JY; Lee TH; Suk K; Cha HS; Koh EM; Yagita H; Lee MS Autoimmunity; 2002 Feb; 35(1):15-20. PubMed ID: 11908702 [TBL] [Abstract][Full Text] [Related]
39. Fas/Fas Ligand pathways gene polymorphisms in pediatric renal allograft rejection. Fadel FI; Elshamaa MF; Salah A; Nabhan M; Rasheed M; Kamel S; Kandil D; Thabet EH Transpl Immunol; 2016 Jul; 37():28-34. PubMed ID: 27109035 [TBL] [Abstract][Full Text] [Related]
40. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases. Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]